Back to Brevan Howard Capital Management LP Brevan Howard Capital Management LP

AGIOAGIO

Showing 8 of 11 quarters

Position history for Brevan Howard Capital Management LPBrevan Howard Capital Management LP's holdings in Agios Pharmaceuticals, Inc.

Yes. Brevan Howard Capital Management holds 9,290 shares of AGIO (Agios Pharmaceuticals), worth $344,752, as of its Q2 2026 13F filing. It reduced the position by 15,179 shares (-62.0%) from Q1 2026. Brevan Howard Capital Management has held AGIO since Q2 2025, across 5 quarterly 13F filings.

Current Value

$344,752

Current Shares

9,290

Total Value Change

-$131,849

Total Shares Change

-1,437

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
9,290
-62.0%
$344,7520.0%$37.11
0
2026-Q1
Increased
24,469
+26.6%
$866,5700.0%$33.83
31
2025-Q4
Increased
19,336
+60.2%
$526,3260.0%$27.22
35
2025-Q3
Decreased
12,071
-58.6%
$484,5300.0%$40.14
0
2025-Q2
New
29,177
—
$970,4270.0%$33.26
35
2025-Q1
Exited
0
-100.0%
$00.0%$29.30
0
2024-Q4
Increased
47,326
+341.2%
$1.6M0.0%$32.86
41
2024-Q3
Decreased
10,727
-22.4%
$476,6010.0%$44.43
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used